The growing interest in bacteriophage (phage) applications across medical, industrial, and molecular fields necessitates rapid and efficient production of high-titer, homogeneous, and purified phage stocks. These stocks should be free from bacterial cells, debris, culture media, and endotoxins. Traditional phage concentration and purification methods are often time-consuming and may compromise phage yield or viability. The Phage On Tap (PoT) protocol offers a rapid, efficient approach for producing homogeneous, high-titer phage stocks. This protocol combines centrifugation, 0.22 μm filtration, and chloroform treatment with ultrafiltration for concentration and washing, resulting in stable stocks stored at 4°C. This method has been tested on T4 (E. coli), T3 (E. coli), T5 (E. coli), and Spp1 (B. subtilis), is broadly applicable to other tailed phages, and supports laboratory-scale production of high-quality, reproducible phage stocks for research and therapeutic development.